Rescuing drug discovery: in vivo systems pathology and systems pharmacology

被引：0

作者：

Jan van der Greef

Robert N. McBurney

机构：

[1] TNO Systems Biology,

[2] Netherlands Organization for Applied Scientific Research,undefined

[3] Utrechtseweg 48,undefined

[4] PO BOX 360,undefined

[5] Centre for Medical Systems Biology/Leiden Amsterdam Centre for Drug Research,undefined

[6] Einsteinweg 55,undefined

[7] PO BOX 9502,undefined

[8] BG Medicine,undefined

[9] Inc.,undefined

[10] BG Medicine,undefined

[11] Inc.,undefined

来源：

Nature Reviews Drug Discovery | 2005年 / 4卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The pharmaceutical industry is currently beleaguered by close scrutiny from the financial community, regulators and the general public. Productivity, in terms of new drug approvals, has generally been falling for almost a decade and the safety of a number of highly successful drugs has recently been brought into question. Here, we discuss whether taking an in vivo systems approach to drug discovery and development could be the paradigm shift that rescues the industry.

引用

页码：961 / 967

页数：6

共 50 条

[21] Systems Pharmacology for Investigation of the Mechanisms of Action of Traditional Chinese Medicine in Drug Discovery
Zhang, Wenjuan
Huai, Ying
Miao, Zhiping
Qian, Airong
Wang, Yonghua
FRONTIERS IN PHARMACOLOGY, 2019, 10
[22] Providing data science support for systems pharmacology and its implications to drug discovery
Hart, Thomas
Xie, Lei
EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (03) : 241 - 256
[23] A Quantitative Systems Pharmacology Model of Colonic Motility to Aid Drug Discovery and Development
Zhang Liming
Raibatak, Das
Lucia, Wille
Chen Chunlin
Jangir, Selimkhanov
Jill, Wykosky
Wendy, Winchester
Cristina, Almansa
John, Burke
Fei, Hua
Majid, Vakilynejad
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S71 - S71
[24] Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development
Agoram, Balaji M.
Demin, Oleg
DRUG DISCOVERY TODAY, 2011, 16 (23-24) : 1031 - 1036
[25] PL Translational pharmacokinetics/pharmacodynamics (PKPD) and systems pharmacology in drug discovery and development
van der Graaf, P. H.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2015, 38 : 64 - 64
[26] Towards the Integration of Quantitative and Systems Pharmacology into Drug Discovery: a Systems Level Understanding of Therapeutic and Toxic Effects of Drugs
Perez Nueno, Violeta I.
CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (46) : 6881 - 6884
[27] In vitro and ex vivo systems at the forefront of infection modeling and drug discovery
Shi, Di
Mi, Gujie
Wang, Mian
Webster, Thomas J.
BIOMATERIALS, 2019, 198 : 228 - 249
[28] Systems Pharmacology-Based Precision Therapy and Drug Combination Discovery for Breast Cancer
Cui, Ze-Jia
Gao, Min
Quan, Yuan
Lv, Bo-Min
Tong, Xin-Yu
Dai, Teng-Fei
Zhou, Xiong-Hui
Zhang, Hong-Yu
CANCERS, 2021, 13 (14)
[29] Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery
Kell, Douglas B.
Goodacre, Royston
DRUG DISCOVERY TODAY, 2014, 19 (02) : 171 - 182
[30] Quantitative systems pharmacology approaches to increase confidence in rationale for drug discovery and development programs
Musante, Cynthia J.
Allen, Richard
Rieger, Theodore R.
Thompson, W. Clayton
DRUG METABOLISM REVIEWS, 2016, 48 : 11 - 11

← 1 2 3 4 5 →